Frontlight ResearchEarly access
CompletedPhase 4
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 90 people enrolled
- Started
- 1 Mar 2024
- Ended
- 15 Jan 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 0.9% Sodium Chloride Injection
- Dexamethasone 4 Mg/mL Injectable Solution
- Dexmedetomidine injection
- Record updated
- 11 May 2026
Who can take part
- Age
- 18 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- patients undergoing primary posterior lumbar decompression and stabilization with instrumentation involving multi-levels in the lumbar region,
- aged >18 years and <100 years
- ASA physical status 1, 2 or 3
Who cannot take part
- history of opioid abuse,
- infection of the puncture site,
- aged <18 years and >100 years
- refuse to participate,
- ASA 4 and 5
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Effect of perineurial dexamethasone and dexmedetomidine on erector spinal plane block duration for spine surgery.
The 3 groups in the trial
- placeboPlacebo, for comparison
0.2% ropivacaine for erector spinae plane block
Treatment: 0.9% Sodium Chloride Injection
- DexamethasoneExisting treatment, for comparison
0.2% ropivacaine + 4mg Dexamethasone for erector spinae plane block
Treatment: Dexamethasone 4 Mg/mL Injectable Solution
- DexmedetomidineExisting treatment, for comparison
0.2% ropivacaine + 50ug Dexmedetomidine for erector spinae plane block
Treatment: Dexmedetomidine injection
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 11 May 2026